Chinese Liver Cancer Clinical Survey

NCT03161925 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2017-05-22

No results posted yet for this study

Summary

In order to make better use of clinical resources of the real world, strengthen the standardization of PLC diagnosis and treatment, and constantly improve the academic level of liver cancer in China, we intends to launch "Chinese Liver Cancer clinical Survey" project in cancer specialized hospitals and large general hospitals and to explore the best clinical pathway of PLC multidisciplinary consultation.

Conditions

  • Primary Liver Cancer

Sponsors & Collaborators

  • Beijing Insight Science & Technology Co. Ltd.

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-28
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03161925 on ClinicalTrials.gov